Skip to content

Study · Measured the body's own peptide · 1993

2 results

Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis.

Medeiros LJ, Bhagat SK, Naylor P, Fowler D, Jaffe ES, Stetler-Stevenson M

Archives of pathology & laboratory medicine1 Mar 1993Cited by 13 (Europe PMC)

PMID8382915 (opens in a new tab)PepBankPUB-08382915
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelCase report or seriesOther

    In a patient with malignant thymoma and T-cell lymphocytosis, serum thymosin alpha‑1 was markedly elevated.

    In plain wordsIn one patient with thymoma, the body's own thymosin alpha‑1 level in the blood was markedly raised.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseSerum thymosin alpha 1 level
    Study

    n = 1

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Serum samples from this patient were also analyzed for thymic hormones; the level of thymosin alpha 1 was markedly elevated
    1 context sentence
    Summary · context
    We describe another patient with a lymphocyte-rich malignant thymoma associated with peripheral T-cell lymphocytosis.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelCase report or seriesOther

    In a patient with malignant thymoma and T-cell lymphocytosis, serum thymosin beta‑4 was decreased.

    In plain wordsIn one patient with a thymus tumor, the body's own thymosin beta‑4 level in blood was low.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    DecreaseSerum thymosin beta 4 in thymoma with T-cell lymphocytosis
    Study

    n = 1

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    that of thymosin beta 4 was decreased.
    1 context sentence
    Summary · context
    We describe another patient with a lymphocyte-rich malignant thymoma associated with peripheral T-cell lymphocytosis.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.